Plasma Fibrinolytic Activity Following Oral Anabolic Steroid Therapy

Summary

Six anabolic steroids were assessed for their ability to enhance plasma fibrinolytic activity in males with ischaemic heart disease. Five 17α-alkylated steroids (Ethyloestrenol, Norethandrolone, Methandienone, Methylandrostenediol and Oxymetholone) were examined and all produced a significant increase in plasma plasminogen activator as measured by the euglobulin lysis time. The only non-17α-alkylated steroid studied (Methenolone acetate) failed to enhance fibrinolysis. The 17α-alkylated steroids studied all deserve more detailed evaluation of their long term effects on plasma fibrinolytic activity.

• References

• 1 Back N, Wilkens H, Barlow B, and Czarnecki J. 1968; Fibrinolytic studies with biguanide derivatives. Annals of the New York Academy of Sciences 148: 691.
• 2 Chakrabarti R, Hocking E. D, Fearnley G. R, Mann R. D, Attwell T. N, and Jackson D. 1968; Fibrinolytic acitivity and Coronary artery disease. Lancet I: 987.
• 3 Chakrabarti R, Evans J. F, and Fearnley G. R. 1970; Effect on Platelet stickiness and fibrinolysis of phenformin combined with ethyloestrenol of stanozolol. Lancet I: 591.
• 4 Davidson J. F, Lochhead M, McDonald G. A, and McNicol G. P. 1972; Fibrinolytic enhancement by Stanozolol. A double blind trial. British Journal of Haematology 22: 543.
• 5 Dixon W. J, and Massey F. J. 1957. Introduction to Statistical Analysis. 2nd Edition.. 124. McGraw Hill Book Company Incorporated.;
• 6 Fearnley G. R, and Chakrabarti R. 1964; Pharmacological enhancement of fibrinolytic activity of blood. Journal of Clinical Pathology 17: 328.
• 7 Fearnley G. R, Chakrabarti R, and Evans J. F. 1969; a Fibrinolytic and defibrin-ating effect of phenformin plus ethyloestrenol in vivo. Lancet 1: 910.
• 8 Fearnley G. R. 1969. b Fibrinolysis. In: Recent Advances in Blood Coagulation. Poller L. (ed.) Churchill; London: 229.
• 9 Isacson S, and Nilsson I. M. 1970; Effect of treatment with combined Phenformin and Ethyloestrenol on the coagulation and fibrinolytic systems. Scandinavian Journal of Haematology 7: 404.
• 10 Isacson S. 1971; Low fibrinolytic activity of blood and vein walls in venous thrombosis. Scandinavian Journal of Haematology, Supplement 16: 21.
• 11 McNicol G. P, Gale S. B, and Douglas A. S. 1963; In vitro and In vivo studies of a preparation of Urokinase. British Medical Journal I: 909.
• 12 Merskey C, Kleiner G. J, and Johnson A. J. 1966; Quantitative estimation of split products of fibrinogen in human serum, relation to diagnosis and treatment. Blood 28: 1.
• 13 Nilsson I. M, and Olow B. 1962; Fibrinolysis induced by streptokinase in man. Acta Chirurgica Scandinavica 123: 247.
• 14 Nilsson I. M, Hedner U, and Isacson S. 1947 Phenformin and Ethyloestrenol in recurrent venous thromboses. Proceedings of the 2nd International Congress on Synthetic Fibrinolytic Agents, Paris (in press).
• 15 Sherry S, and Alkjaersig N. 1957; A study of the fibrinolytic enzyme of human plasma. Thrombosis et Diathesis Haemorrhagica 1: 264.
• 16 Wolf P. 1967; Coagulation fibrinolysis (Letter). Lancet I: 1226.